BioCentury
ARTICLE | Company News

University of Oxford cancer, pharmacogenetics news

January 23, 2012 8:00 AM UTC

The University of Oxford spun out Oxford Cancer Biomarkers Ltd. (Oxford, U.K.) to discover cancer biomarkers and provide cancer consulting services. CRO Quintiles Transnational Corp. (Research Triangle Park, N.C.) made a £3 million ($4.6 million) investment in the newco, which represents a 27.5% stake. ...